statements

Alchemist Ltd.

NSE: ALCHEM

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

3.15+0.0 (+0.00%)

21 Mar, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Alchemist Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2007 Jun 30	2008 Mar 31	2009 Mar 31	2010 Mar 31	C 2011 Mar 31	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	TTM Jun 30
	2007 Jun 30	2008 Mar 31	2009 Mar 31	2010 Mar 31	C 2011 Mar 31	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	TTM Jun 30
Period length: Source:	12M AR	9M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	385	308	389	399	503	886	1,457	1,508	350	105	24	27	27	14	0	0
Cost of Operating Revenue	344	277	346	350	441	822	1,378	1,432	312	91	27	27	27	16	0	-
Gross Profit	40	31	43	48	62	64	79	76	37	14	-3	0	0	-2	0	-
Gross Margin	10.5	10.2	11.0	12.1	12.4	7.2	5.4	5.0	10.7	13.4	-11.3	-0.8	0.1	-14.3	94.5	-
Total Operating Expenses	359	283	362	372	477	863	1,429	1,490	398	165	61	44	87	72	0	0
Operating Profit	25	25	27	26	26	23	28	18	-49	-60	-37	-17	-60	-58	0	0
Operating Margin	6.6	8.1	6.9	6.6	5.1	2.6	1.9	1.2	-13.9	-56.7	-153.9	-65.1	-225.0	-400.5	28.1	16.3
Financing Income/(Expense) - Net	-7	-6	-8	-7	-4	6	9	-4	-5	-5	-2	-2	-1	-1	0	0
Profit before Taxes	19	14	19	19	22	31	38	28	-39	-52	-108	-16	-61	-58	-2	-2
Income Taxes	5	3	5	4	9	7	9	15	-1	2	-1	0	-11	-11	0	-
Profit after Tax	14	11	14	15	13	24	27	14	-36	-48	-107	-17	-50	-47	-2	-2
PAT Margin	3.5	3.4	3.5	3.8	2.6	2.7	1.9	0.9	-10.2	-46.0	-444.1	-63.6	-185.7	-324.2	-418.5	-490.7
EPS - Basic - ex Extraordinary Items	11.13	8.74	11.46	12.86	10.65	19.50	20.56	10.44	-26.37	-35.67	-79.15	-12.47	-36.61	-34.46	-3.89	-
EPS - Diluted - ex Extraordinary Items	11.13	8.74	11.46	12.86	10.65	19.50	20.05	10.44	-26.37	-35.67	-79.15	-12.47	-36.61	-34.46	-3.89	-
EBIT	25	25	27	26	26	23	28	18	-49	-60	-37	-17	-60	-58	0	0
EBITDA	34	31	35	36	38	36	41	33	-26	-33	-29	-10	-53	-51	0	0
EBITDA Margin	8.8	10.2	9.1	9.1	7.5	4.0	2.8	2.2	-7.4	-31.7	-121.0	-35.9	-199.2	-354.4	33.6	22.4

Balance Sheet

Abridged

Understanding Balance Sheet

Alchemist Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2007 Jun 30	2008 Mar 31	C 2009 Mar 31	2010 Mar 31	C 2011 Mar 31	C 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31
	2007 Jun 30	2008 Mar 31	C 2009 Mar 31	2010 Mar 31	C 2011 Mar 31	C 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	77	64	78	81	86	150	104	658	548	497	489	486	438	391
Long-Term Investments	12	25	24	24	23	2	2	2	2	251	173	171	171	171
Property Plant & Equipment - Net	179	178	193	206	251	309	395	434	410	160	148	142	138	133
Total Non-Current Assets	195	206	230	246	308	362	462	500	481	429	346	336	336	341
Total Assets	276	276	308	327	394	512	566	1,159	1,030	926	835	822	774	733
Total Current Liabilities	43	40	41	43	86	81	44	193	192	169	172	166	164	161
Long Term Debt	83	85	108	116	169	302	294	774	699	719	735	745	755	763
Total Non-Current Liabilities	91	93	118	128	187	326	325	812	737	733	747	756	759	768
Total Liabilities	134	133	159	171	272	407	369	1,005	928	902	918	922	924	929
Total Shareholders' Equity	142	143	149	156	121	105	178	136	87	24	-83	-100	-150	-196
Minority Interest	-	-	-	-	-	-	19	17	15	0	0	0	0	0
Total Equity	142	143	149	156	121	105	197	154	101	24	-83	-100	-150	-196
Total Liabilities & Equity	276	276	308	327	394	512	566	1,159	1,030	926	835	822	774	733

Cash Flow

Abridged

Understanding Cash Flow Statement

Alchemist Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2007 Jun 30	2008 Mar 31	2009 Mar 31	2010 Mar 31	C 2011 Mar 31	C 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31
	2007 Jun 30	2008 Mar 31	2009 Mar 31	2010 Mar 31	C 2011 Mar 31	C 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31
Period length: Source:	12M AR	9M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	21.99	17.30	22.63	25.67	28.60	43.36	41.77	40.90	-19.10	-16.65	-31.17	-9.80	-7.25	-5.00
Working Capital - Increase/(Decrease)	25.08	14.51	-5.78	-0.36	-12.91	-21.31	-21.48	-250.90	-70.03	-8.04	14.22	-6.00	-0.77	0.42
Net CF from Operating Activities	47.07	31.81	16.85	25.31	15.70	22.05	20.30	-210.00	-89.13	-24.69	-16.95	-15.80	-8.02	-4.58
Capital Expenditures - Net	18.22	7.38	25.27	24.09	63.85	78.62	113.80	56.96	7.83	-6.68	-4.94	-0.82	-0.11	0.18
Net CF from Investing Activities	-20.03	-20.27	-25.88	-26.22	-65.42	-57.27	-113.85	-67.20	-15.73	-2.47	4.89	3.49	-2.96	-0.17
Dividends Paid - Cash - Total	3.58	3.58	2.87	2.86	5.37	6.01	2.38	1.59	-	-	-	-	-	-
Stock - Issuance/(Retirement) - Net	-48.02	-6.25	-5.55	-5.78	-42.31	-37.63	67.63	-51.22	-1.02	-0.54	-0.01	-	-0.03	-
Debt - LT & ST - Issuance/(Retirement) - Total	24.69	1.77	13.21	7.74	98.55	132.20	-10.13	479.90	-69.47	19.80	13.18	11.84	10.23	5.18
Net Cash Flow from Financing Activities	-26.92	-8.06	4.80	-0.90	50.87	92.19	53.24	427.10	-70.49	19.26	13.19	11.84	10.21	5.18
Free Cash Flow to Equity	53.54	26.20	4.79	8.96	50.40	75.63	-103.64	212.94	-166.43	1.78	1.16	-3.14	2.32	0.43
Free Operating CF net dividend	25.27	20.85	-11.29	-2.12	-56.44	-62.88	-96.42	-268.72	-102.75	-30.09	-17.06	-15.80	-8.02	-4.75
Free Operating CF	28.85	24.43	-8.42	0.74	-51.07	-56.87	-94.04	-267.14	-102.75	-30.09	-17.06	-15.80	-8.02	-4.75

Business Segment Analysis

FY End:

Mar 13

Alchemist Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales

Pharma & Chemicals (90.2%)₹ 1,314.61 CrAgricultural business (9.8%)₹ 142.83 Cr

Assets

Agricultural business (63.0%)₹ 81.68 CrPharma & Chemicals (35.5%)₹ 46.00 CrUnallocated (1.6%)₹ 2.07 Cr

Regional Segment Analysis

Alchemist Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Alchemist Ltd.

Historical Segment Analysis

Track how Alchemist Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2010 Mar 31	2011 Mar 31
	2010 Mar 31	2011 Mar 31
Agricultural business	239	301
Pharma & Chemicals	21	25

Frequently Asked Questions

What is the revenue of Alchemist Ltd.?

The latest trailing twelve month revenue of Alchemist Ltd. is -. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Alchemist Ltd.?

The latest trailing twelve month net profit (PAT) of Alchemist Ltd. is -. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Alchemist Ltd.?

The operating margin of Alchemist Ltd. is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of Alchemist Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Alchemist Ltd. is -. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Alchemist Ltd.?

The debt-to-equity ratio of Alchemist Ltd. stands at -. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Alchemist Ltd.?

The book value per share of Alchemist Ltd. is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of Alchemist Ltd.?

Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Alchemist Ltd. report consolidated or standalone financials?

Alchemist Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.